U.S. Healthtech Stock News

Wondering whether Innodata's share price around US$45.64 still offers value, or if most of the opportunity is already reflected in the stock. The stock has moved sharply in the short term, with a 9.0% return over the last week and 18.6% over the last month, while year to date it is down 13.9% and the 1 year return sits at 18.5%, with a very large return over 3 and 5 years. Recent interest in data and AI related services has kept Innodata on many investors' watchlists. Coverage has focused on...

Palo Alto Networks (PANW) is back in focus after a wave of insider and institutional buying, fresh AI security moves including the Portkey acquisition, and CEO warnings about AI exposing software vulnerabilities at higher speed. See our latest analysis for Palo Alto Networks. Despite recent pullbacks, including a 1-day share price return of 0.31% and a 1-year total shareholder return decline of 2.5%, Palo Alto Networks still shows longer term strength, with 3-year and 5-year total shareholder...

LCI Industries (LCII) has just opened its 2026 reporting year with a Q1 update that follows a 2025 finish where Q4 revenue was US$932.7 million and basic EPS came in at US$0.77, supported by trailing 12 month EPS of US$7.59 on revenue of US$4.1 billion. The company has seen quarterly revenue range from US$803.1 million in Q4 2024 to US$1.1 billion in Q2 2025, while basic EPS over that stretch moved between US$0.37 and US$2.56, which gives a clear sense of how top line swings have flowed...

Nomad Foods Limited recently paid a quarterly cash dividend of US$0.17 per share on May 28, 2026, to shareholders of record as of the May 12, 2026 ex-dividend and record date. This dividend underscores the company’s emphasis on consistent cash returns, adding an income layer to its frozen-food-focused business and innovation efforts. We’ll now assess how this steady US$0.17 quarterly payout and capital return emphasis may influence Nomad Foods’ broader investment narrative. The future of...

Aeluma, Inc. recently presented its compound semiconductor technologies at the SPIE Defense + Security Conference 2026 at the Gaylord Palms Resort & Convention Center in National Harbor, Maryland, underscoring its engagement with defense and advanced imaging stakeholders. This appearance at a specialized defense and security forum highlights how Aeluma is positioning its scalable optical and sensing solutions directly in front of key government and industry decision-makers. We’ll now examine...

Defiance launched the Daily Target 2X Long AMKR ETF (ticker: AMKL), a leveraged ETF tied solely to Amkor Technology shares. The product offers daily 2x exposure to NasdaqGS:AMKR, introducing a new trading vehicle focused entirely on the stock. The ETF structure can influence short term trading flows, liquidity and volatility in Amkor Technology stock. The launch of AMKL comes at a time when NasdaqGS:AMKR has drawn strong investor attention, with the stock at $76.71 and showing a 344.0%...

Why Star Bulk Carriers is on investors’ radar today Star Bulk Carriers (SBLK) has drawn fresh attention after recent share price moves, with the stock showing double digit total returns over the past year, 3 years and 5 years. See our latest analysis for Star Bulk Carriers. The recent 1-day share price return of 5.45% to $26.68 adds to a 37.74% year to date share price return and a 1-year total shareholder return of 82.95%. This points to strong, sustained momentum rather than a short term...

Alphabet's classified AI contract with the U.S. Department of Defense has triggered internal employee protests and fresh scrutiny of the company's AI ethics policies. Staff at Google DeepMind have begun unionization efforts, citing concerns about defense work and data governance linked to the contract. These developments are drawing attention from governance focused investors ahead of Alphabet's 2026 annual shareholder meeting. For investors watching NasdaqGS:GOOGL, the controversy arrives...

Mirum Pharmaceuticals recently reported that its Phase 2b VISTAS trial of volixibat in primary sclerosing cholangitis met the primary endpoint, showing a statistically significant reduction in cholestatic pruritus versus placebo and a safety profile consistent with IBAT inhibition. The company is now preparing for a pre-New Drug Application meeting with the FDA in summer 2026 and aims to file an NDA in the second half of 2026, positioning volixibat as a potential first approved therapy for...

In April 2026, Kopin Corporation announced a collaboration with Fabric.AI to develop MicroLED-based Neural I/o optical interconnects for AI data centers, backed by a US$15,000,000 purchase order and an exclusive manufacturing role alongside a 19.9% stake in Fabric.AI. In the same period, Kopin also secured a US$3,200,000 initial order for its Sentinel FPV optical module for next-generation military drone goggles, marking its entry into the FPV drone vision market with a system designed to...

Addus HomeCare (ADUS) has just put fresh numbers on the table for Q1 2026, coming off a Q4 2025 result that featured US$373.1 million in revenue and basic EPS of US$1.61, supported by trailing 12 month EPS of US$5.31 on revenue of about US$1.4 billion. Over recent quarters the company has seen revenue move from US$289.8 million in Q3 2024 to US$373.1 million in Q4 2025. Quarterly basic EPS has ranged from US$1.07 to US$1.61 over the same period, setting up Q1 2026 against a backdrop of 30.3%...

If you are wondering whether Trane Technologies at around US$477 a share still offers value, the starting point is to separate price action from what the business might actually be worth. The stock has recently been active, with a 0.7% decline over the last 7 days, an 11.8% return over 30 days, a 20.0% return year to date and an 18.5% return over 1 year, which can change how the market views its risk and return trade off. Recent coverage has focused on Trane Technologies as a major player in...

FDA clearance creates a new use case for Tandem Diabetes Care stock Tandem Diabetes Care (TNDM) just received US FDA clearance for its Control-IQ+ technology in pregnancies complicated by type 1 diabetes, making its t:slim X2 and Tandem Mobi systems the only automated insulin delivery options approved for this use in the country. See our latest analysis for Tandem Diabetes Care. The FDA clearance comes after a mixed period for the stock, with a 7 day share price return of 4.24% and a 30 day...

Quarterly results trigger reassessment of profitability progress GDS Holdings (NasdaqGM:GDS) is under pressure after its latest quarterly report, as investors reacted to narrowing adjusted EBITDA margins and revenue that did not meet analyst expectations despite a year-over-year reduction in net losses. See our latest analysis for GDS Holdings. The quarterly miss on margins comes after a strong run in the stock, with a 17.37% year to date share price return and a very large 3 year total...

If you are wondering whether Global Partners at around US$48.51 is offering good value right now, this article walks through what the current price may or may not be pricing in. The stock has returned 2.7% over the last 7 days, 7.8% over 30 days, 14.8% year to date and 2.5% over 1 year, which gives useful context before comparing those moves with underlying valuation. Recent news flow around Global Partners has focused on the company’s position in the wider energy sector and how investors...

AT&T (NYSE:T) and Geoforce are partnering to support ultra rugged industrial asset tracking devices on AT&T's network. The collaboration centers on Geoforce's GT1c device, aimed at large scale tracking of equipment and assets in harsh industrial conditions. The partnership extends AT&T's role in industrial IoT connectivity beyond its traditional telecom services. For AT&T, this move adds another business use case on top of its core wireless and fiber operations by leaning into the...

OSI Systems (OSIS) has just reported its Q3 2026 results, with quarterly revenue of US$464.1 million and basic EPS of US$2.31, set against trailing twelve month revenue of about US$1.8 billion and basic EPS of US$9.11 that reflect the broader earnings run rate. Over recent periods the company has seen revenue move from US$419.8 million and EPS of US$2.26 in Q2 2025 to US$464.1 million and EPS of US$2.31 in Q2 2026. At the same time, trailing twelve month EPS stepped up from US$7.96 to US$9.11...

Investors may be wondering if Vita Coco Company's strong run has already priced in the story, or if there is still value left on the table. The stock recently closed at US$67.79, with returns of 31.3% over 7 days, 40.5% over 30 days, 26.8% year to date and 93.7% over the last year, while the 3 year return sits at 178.4%. Recent coverage has focused on Vita Coco as a branded beverage company in a competitive category, with attention on how the business is positioned within consumer staples...

What Fastly’s Recent Share Move Means for Investors Fastly (FSLY) has caught investor attention after a sharp single day return of 17.7%, adding to a 31.4% gain over the past week, even as the stock shows mixed performance over the past month and past 3 months. See our latest analysis for Fastly. The latest move builds on strong short term share price momentum but also sits within a much larger trend, with a 1 year total shareholder return of 455.06% and a 3 year total shareholder return of...

Apollo Global Management (NYSE:APO) is joining Anthropic's $1.5 billion AI services joint venture as a founding partner. The partnership aims to deliver Claude AI services to mid-sized portfolio and independent enterprises. Apollo will work alongside firms such as Blackstone, Hellman & Friedman, and Goldman Sachs in this mid-market AI initiative. For investors tracking NYSE:APO, this move adds a new dimension to a stock that has seen very large gains over the past 5 years and 120.0% over 3...

Ichor Holdings (ICHR) is back on investors radar after reporting first quarter 2026 results that topped revenue and non GAAP EPS expectations, alongside guidance pointing to higher second quarter revenue and margins. See our latest analysis for Ichor Holdings. The first quarter news has come on the back of a powerful run, with a 30 day share price return of 40.84%, a 90 day share price return of 141.95% and a 1 year total shareholder return of 323.56%. This points to strong momentum tied to...

In late April 2026, United Parcel Service, Inc. reported first-quarter 2026 revenue of US$21,202 million and net income of US$864 million, while reaffirming full-year 2026 revenue guidance of about US$89.70 billion. At the same time, Amazon’s launch of Amazon Supply Chain Services opened its logistics network to outside businesses, intensifying competitive pressure on UPS’s core small and medium-sized business customer base. Next, we’ll examine how Amazon’s new end-to-end logistics offering...

Nextracker recently experienced a 2.5% daily underperformance versus the broader market, as investors reacted to an upcoming May 12, 2026 earnings report that is projected to show a 31.01% year-over-year EPS decline. Despite this expected earnings pressure, the company’s Zacks Rank #2 (Buy) highlights ongoing analyst confidence, suggesting a tension between near-term profitability concerns and longer-term optimism. Against this backdrop of anticipated EPS weakness and supportive analyst...

Pediatrix Medical Group earnings snapshot Pediatrix Medical Group (MD) has reported its latest quarterly results with Q4 2025 revenue of US$493.8 million, basic EPS of US$0.40 and net income, excluding extra items, of US$33.7 million. The company has seen revenue move from US$502.4 million in Q4 2024 to US$493.8 million in Q4 2025, while basic EPS shifted from US$0.36 to US$0.40 over the same period, giving a view of how the top line and EPS have been tracking into the new year. With trailing...